Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].

Problemy tuberkuleza i boleznei legkikh - 1 Jan 2003

Tashpulatova F K

Abstract excerpt

A hundred and sixty-seven patients with pulmonary tuberculosis were examined to study the genetic predisposition to adverse reactions (AR) from chemical drugs. The phenotype of haptoglobin carriage, the type of, the activity of the enzyme glucose-6-phosphate dehydrogenase inactivation were used as a genetic marker. If with a poor combination of the above parameters AR developed in 100%; with their relative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genotype

Share to Phytotherapy

Share to Tuberculosis, Pulmonary

Source

Identifiers

PMID: 12899021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].PMID 12899021Read ↗

[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].Semantic proximity Read ↗

[Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].Semantic proximity Read ↗

[The role of human genetic factors in susceptibility to tuberculosis].Semantic proximity Read ↗

[Significance of hereditary factors in tuberculosis and other granulomatous lung diseases].Semantic proximity Read ↗

[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].Semantic proximity Read ↗

[The role of genetically determined haptoglobin phenotypes in patients with destructive pulmonary tuberculosis].Semantic proximity Read ↗

[Genetic variants of haptoglobin in patients with destructive pulmonary tuberculosis].Semantic proximity Read ↗

[The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers].Semantic proximity Read ↗

[Polymorphism of genes of the renin-angiotensin system ACE, AT1R, and AT2R in patients with pulmonary tuberculosis].Semantic proximity Read ↗

[Role of a comprehensive genetic prognosis in the treatment and prevention of respiratory tuberculosis in adolescents].Semantic proximity Read ↗

[Immune status in patients with bone and joint tuberculosis and effect of HLA genotype].Semantic proximity Read ↗

[The role of phenotypic factors in predicting the effectiveness of pharmacological prevention of tuberculosis in children].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.